Pharmabiz1h
Govt should roll out comprehensive National Cancer Care Policy with dedicated funding outlay: FICCI-EY Parthenon Report
Govt should roll out comprehensive National Cancer Care Policy with dedicated funding outlay: FICCI-EY Parthenon Report: Our ...
Pharmabiz23m
Neurizon Therapeutics receives positive opinion on orphan medicinal product designation for NUZ-001 in Europe
Neurizon Therapeutics Limited (Neurizon), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, announced it has received notice of a positive opinion from the European ...
Pharmabiz1h
EnteroBiotix reports positive results from phase 1b IMPuLCE study of EBX-102 in liver cirrhosis
EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, announced positive results from its phase 1b IMPuLCE study ...
Pharmabiz2h
GE HealthCare, RadNet collaborate to transform imaging systems and accelerate the adoption of AI with SmartTechnology
Chicago, Illinois Tuesday, November 12, 2024, 14:00 Hrs [IST] ...
Pharmabiz8h
Oversimplification about integration of traditional & modern treatment systems creates confusion: Dr Kotecha
Oversimplification about integration of traditional & modern treatment systems creates confusion: Dr Kotecha: Peethaambaran ...
Pharmabiz1d
DGTR releases list of registered parties on anti-dumping investigation on sodium citrate imports from China
The Directorate General of Trade Remedies (DGTR), under the ministry of commerce and industry, has released a list of registered interested parties regarding the ongoing Second Sunset Review ...
Pharmabiz2h
NABL to usher in accreditation insights for reference material producers in Raipur and Hyderabad
Two exclusive conferences focusing on "Reference Material (RM) Producers" organized by National Accreditation Board for Testing and Calibration Laboratories (NABL) are scheduled to be held on January ...
Pharmabiz1d
MSMEs in confusion as govt is keeping mum on demand for extending implementation of revised Schedule M
Whilst the timeline set for adhering to the revised Schedule M of the Drugs and Cosmetics Act ends on December 31 for pharmaceutical companies with a turnover of less than Rs. 250 crore, the union ...
Pharmabiz1d
Karnataka Ayush sector upbeat on recent amendment to renew manufacturing & loan licenses to perpetuity
The recent amendments brought by the Union Ministry of Ayush to the Drugs and Cosmetics Rules, 1945 are significant, as they introduce new regulatory requirements for the manufacturing and sale of ...
Pharmabiz3h
Tectonic Therapeutic to present positive phase 1a results of TX45, a long-acting, Fc-relaxin fusion protein at AHA 2024
Tectonic Therapeutic to present positive phase 1a results of TX45, a long-acting, Fc-relaxin fusion protein at AHA 2024: Watertown, Massachusetts Tuesday, November 12, 2024, 13:00 ...
Pharmabiz4h
Healthium and HSSC ink MoU to enhance certification in skill development for Indian healthcare
Healthium and HSSC ink MoU to enhance certification in skill development for Indian healthcare: Our Bureau, Bengaluru Tuesday, November 12, 2024, 12:15 Hrs [IST] Healthium Medtech ...
Pharmabiz4h
ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions
ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...